News from the MVM project
MVM received the Declaration of Quality System Approval according to CE parameters.
March 23, 2021
Update: Cost-Effective, Easily Manufactured Ventilators for COVID-19 Patients
Article published on Physics of Fluids AIP
Sep 30, 2020
Update: Vexos receives Health Canada Authorization for manufacture of the MVM ventilator
May 5, 2020
Update: The US FDA authorizes the MVM within the scope of the emergency use authorization.
April 11, 2020
First pre-serie of 5 MVM units
Thanks to the first support we have completed production of the first series of units, MVM-PR. Passed stringent qualification tests ISO 80601.
Scientific paper to appear on arXiv on April 13, 2020.
April 10, 2020
Third revised version on arxiv.
April 8, 2020
The MVM is currently in final prototyping to ensure compliance against clinical requirements. Medical certification and regulatory approval are currently being developed in Europe (ISS), the US (FDA) and Canada (Health Canada).
April 3, 2020
MVM has been tested on an ALS-5000 silicon lung, which simulates a breathing patient, at Ospedale San Gerardo in Monza, Italy.
March 31, 2020
Second revised version on arxiv.
March 25, 2020
A public fundraising campaign was lanched online by Cristiano Galbiati and the MVM group.
March 23, 2020
First release on arxiv presenting MVM.
March 21, 2020
The international collaborators have initiated the project using their own funding resources. As the design advances from initial prototypes to final production design, regulatory approval, and eventually manufacture and distribution, additional funding will be required in each country.